Taylor Zachariah, Chory Kayla, Wright Mark, Amatya Anup, Gard Charlotte, Woods Michael E
Urology, Main Line Health, Philadelphia, USA.
Osteopathic Medicine, Burrell College of Osteopathic Medicine, Las Cruces, USA.
Cureus. 2020 Oct 29;12(10):e11234. doi: 10.7759/cureus.11234.
Background Few in-depth reports on cancer epidemiology in New Mexico or the United States-Mexico border region exist. We aim to quantify cancer incidence and survival in New Mexico and the United States-Mexico border region in New Mexico. Methods Incidence and survival were obtained using SEER*Stat 8.3. The data were divided into either New Mexico, or SEER 18 (comprised of the 17 remaining regions) and then further divided by county in New Mexico and by time period. Incidence rates were age-standardized to the 2000 US census. Five-year survival was calculated for each cancer type. Kaplan-Meier survival plots were produced, and significance was determined using log-rank analysis. Results Analysis demonstrated that cancers in New Mexico are diagnosed at a lower rate with the exception of thyroid, liver, and ovarian. Survival is generally lower in New Mexico with 10 of the 14 cancers having worse survival in New Mexico. Only uterine cancer had improved survival in New Mexico (77.9% vs 74.9%, P < .001). Additionally, breast (82.2%), prostate (83.3%), lung and bronchus (13.7%), colorectal (53.7%), melanoma (80.1%), kidney and renal pelvis (61.2%), uterine (78.5%), and ovarian (41.6%) all had lower survival in the border counties. Conclusion Comparing New Mexico to the other regions in the SEER 18 database, both cancer incidence and survival are consistently lower; these findings could be explained by lower access to healthcare, which can result in underreporting and delays in diagnosis.
关于新墨西哥州或美国与墨西哥边境地区癌症流行病学的深入报告很少。我们旨在量化新墨西哥州以及新墨西哥州内美国与墨西哥边境地区的癌症发病率和生存率。方法：使用SEER*Stat 8.3获取发病率和生存率数据。数据分为新墨西哥州组或SEER 18组（由其余17个地区组成），然后在新墨西哥州内按县以及按时间段进一步划分。发病率按2000年美国人口普查进行年龄标准化。计算每种癌症类型的五年生存率。绘制Kaplan-Meier生存曲线，并使用对数秩分析确定显著性。结果：分析表明，除甲状腺癌、肝癌和卵巢癌外，新墨西哥州癌症的诊断率较低。新墨西哥州的总体生存率普遍较低，14种癌症中有10种在新墨西哥州的生存率更差。只有子宫癌在新墨西哥州的生存率有所提高（77.9%对74.9%，P <.001）。此外，乳腺癌（82.2%）、前列腺癌（83.3%）、肺癌和支气管癌（13.7%）、结直肠癌（53.7%）、黑色素瘤（80.1%）、肾和肾盂癌（61.2%）、子宫癌（78.5%）和卵巢癌（41.6%）在边境县的生存率均较低。结论：将新墨西哥州与SEER 18数据库中的其他地区进行比较，癌症发病率和生存率一直较低；这些发现可能是由于获得医疗保健的机会较少，这可能导致报告不足和诊断延迟。
